Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to significant financial misrepresentations and integration issues related to its acquisition of 3M's food safety business, which led to substantial losses for investors during the specified class period [1][6]. Financial Performance - On January 10, 2025, Neogen reported a GAAP net income that was significantly negative, primarily due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition, resulting in a share price decline from $13.07 to $12.36, approximately 5% [3]. - On April 9, 2025, Neogen's quarterly revenue fell by 3.4% to $221 million, leading to another cut in FY25 guidance and a share price drop from $7.04 to $5.02, approximately 28% [4]. - On June 4, 2025, Neogen disclosed a material decline in EBITDA margin attributed to elevated inventory write-offs, causing the share price to decline from $6.00 to $4.96, approximately 17% [5]. Lawsuit Details - The lawsuit alleges that Neogen misrepresented the status of the integration with 3M and failed to disclose the negative impacts of integration issues, misleading investors into believing that the integration was progressing smoothly [6].
Kirby McInerney LLP Reminds Neogen Corporation Investors of Class Action Filing and Encourages Investors to Contact the Firm